1. Home
  2. SPT vs EOLS Comparison

SPT vs EOLS Comparison

Compare SPT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$12.69

Market Cap

485.7M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.41

Market Cap

500.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPT
EOLS
Founded
2010
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.7M
500.0M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
SPT
EOLS
Price
$12.69
$7.41
Analyst Decision
Hold
Buy
Analyst Count
10
6
Target Price
$10.67
★ $15.00
AVG Volume (30 Days)
★ 714.3K
611.3K
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 32.11
1.23
EPS
★ N/A
N/A
Revenue
★ $457,547,000.00
$297,176,000.00
Revenue This Year
$8.10
$12.44
Revenue Next Year
$6.01
$17.37
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.72
11.61
52 Week Low
$4.92
$3.86
52 Week High
$12.73
$9.31

Technical Indicators

Market Signals
Indicator
SPT
EOLS
Relative Strength Index (RSI) 71.60 44.23
Support Level $9.08 $7.07
Resistance Level N/A $7.83
Average True Range (ATR) 0.51 0.32
MACD 0.21 -0.02
Stochastic Oscillator 94.39 44.17

Price Performance

Historical Comparison
SPT
EOLS

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: